Today: 27 April 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

KLA stock price dips: KLAC slips as investors size up India R&D hub push and chip-tool outlook

KLA stock price dips: KLAC slips as investors size up India R&D hub push and chip-tool outlook

KLA Corp shares fell 0.6% to $1,431 in late-morning New York trading Tuesday, trailing the semiconductor ETF. The company announced a new R&D and innovation hub in Chennai, India, to support AI and engineering. Investors are watching for peer earnings later this week and KLA’s dividend timetable, with a $1.90-per-share payout set for March 3.
10 February 2026
···
GE Vernova stock slips from recent highs after 2030 turbine slot deal — what GEV investors watch next

GE Vernova stock slips from recent highs after 2030 turbine slot deal — what GEV investors watch next

GE Vernova shares slipped 0.7% to $796.29 in late-morning New York trading after Maxim Power reserved a 7HA.02 gas turbine slot for 2030 delivery, with a non-refundable deposit due in 2026. The broader market edged higher, while GE Vernova also reported upgrades at InterGen’s Coryton plant in the UK. Investors await the company’s April 22 earnings webcast.
10 February 2026
··
UnitedHealth stock price today: UNH ticks up as Medicare Advantage rate clock and ACA probes hang over insurers

UnitedHealth stock price today: UNH ticks up as Medicare Advantage rate clock and ACA probes hang over insurers

UnitedHealth shares rose 0.8% to $278.04 Tuesday after a volatile open, as investors watched Medicare Advantage payment updates and new federal scrutiny of health insurers. The Centers for Medicare & Medicaid Services projected a 0.09% average payment increase for 2027, with final rates due by April 6. House Republicans subpoenaed eight ACA insurers in a subsidy fraud probe; UnitedHealth was not named. Managed care stocks were mixed.
10 February 2026
·
Hims & Hers stock price slides again as Novo Nordisk lawsuit tightens the screws on Wegovy copies

Hims & Hers stock price slides again as Novo Nordisk lawsuit tightens the screws on Wegovy copies

Hims & Hers Health shares fell 5.6% to $18.25 Tuesday after Novo Nordisk filed a U.S. patent lawsuit seeking to block sales of compounded versions of its Wegovy weight-loss drug. The FDA has said semaglutide is no longer in shortage, tightening rules on compounding. Hims pulled its $49 compounded semaglutide pill days after launch. Investors await Hims’ earnings on Feb. 23.
10 February 2026
···
Booking Holdings stock price rebounds on Gordon Haskett upgrade as BKNG eyes Feb. 18 earnings

Booking Holdings stock price rebounds on Gordon Haskett upgrade as BKNG eyes Feb. 18 earnings

Booking Holdings shares climbed nearly 3% Tuesday after Gordon Haskett upgraded the stock to “buy” with a $5,440 price target. The rebound follows a 5% drop Monday; shares remain well below their July 2025 high. Investors await Booking’s quarterly results and conference call on Feb. 18. Trading volume was above average, with the stock lagging travel peers the previous session.
10 February 2026
··
Flutter Entertainment stock price today: FLUT edges up as UBS cuts target and prediction markets loom

Flutter Entertainment stock price today: FLUT edges up as UBS cuts target and prediction markets loom

Flutter shares rose 0.6% to $155.48 Tuesday morning after UBS cut its price target to $300 but kept a buy rating. The move comes as investors track competition from prediction markets and await Flutter’s fourth-quarter results on Feb. 26. Massachusetts regulators are challenging prediction markets, with Polymarket suing the state attorney general. Flutter’s stock recently ended an eight-week losing streak.
10 February 2026
·
CoreWeave stock slips as lawsuit notices and insider-sale filing hit a hot trade

CoreWeave stock slips as lawsuit notices and insider-sale filing hit a hot trade

CoreWeave shares fell 2% to $94.84 Tuesday, reversing part of Monday’s gain, after a class-action notice and insider-related SEC filing circulated. An entity linked to co-founder Brannin McBee filed to sell shares, while law firms urged investors to join a proposed lawsuit over infrastructure delays. Investors await CoreWeave’s Feb. 26 earnings for updates on capacity and funding. The broader tech sector was steady.
10 February 2026
Lumentum stock price drops as rally cools — here’s what traders watch next

Lumentum stock price drops as rally cools — here’s what traders watch next

Lumentum shares fell 2.4% to $563.33 Tuesday morning after a strong prior session, swinging between $531 and $579 as major indexes edged up. The drop follows a recent rally tied to AI and cloud data-center spending. Last week, Lumentum reported Q2 revenue of $665.5 million and forecast Q3 revenue up to $830 million. Management will appear at tech conferences on Feb. 26 and March 2.
10 February 2026
·
Exxon Mobil stock slips from fresh high as oil steadies and U.S. data looms

Exxon Mobil stock slips from fresh high as oil steadies and U.S. data looms

Exxon Mobil shares slipped 0.5% to $150.49 Tuesday morning after hitting a 52-week high at $151.21 on Monday. Oil prices were little changed, with Brent at $69.31 and WTI at $64.48 as traders watched U.S.-Iran tensions and awaited U.S. inventory data. Chevron and ConocoPhillips also traded lower. Investors are focused on Exxon's Feb. 20 investor update and upcoming U.S. economic reports.
10 February 2026
···
Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention

Eli Lilly stock price dips as $2.4 billion Orna deal and China pact grab attention

Eli Lilly shares fell 0.9% to $1,035.54 Tuesday morning after new deals in cell therapy and China drug development. The company agreed to buy Orna Therapeutics for up to $2.4 billion and struck a collaboration with Innovent Biologics. Investors weighed increased pipeline spending as competition in obesity drugs intensified. Attention turns to an upcoming FDA decision on Lilly’s oral obesity pill.
10 February 2026
··
Palo Alto Networks (PANW) stock nudges higher as Nasdaq flags Feb 11 close for CyberArk deal

Palo Alto Networks (PANW) stock nudges higher as Nasdaq flags Feb 11 close for CyberArk deal

Palo Alto Networks shares rose 0.5% to $166.88 Tuesday as Nasdaq set a tentative Feb. 11 close for its $25 billion merger with CyberArk. CyberArk stock will be halted after-hours Tuesday and suspended Feb. 12. Palo Alto reports earnings Feb. 17, with investors watching for integration plans. Cybersecurity stocks traded higher across the board.
10 February 2026
····
Netflix stock price jumps 3% as Paramount ups the pressure in Warner Bros battle

Netflix stock price jumps 3% as Paramount ups the pressure in Warner Bros battle

Netflix shares rose 3.1% to $84.00 after Paramount raised its bid for Warner Bros. Discovery and offered to cover a $2.8 billion breakup fee tied to Netflix’s deal. Paramount extended its tender offer deadline to March 2 and added a “ticking fee” for WBD holders if closing is delayed past 2026. Warner Bros. Discovery shares gained 1.8%. Traders are watching the antitrust review and the new timeline.
10 February 2026
···
Oracle stock price today jumps again as OpenAI-linked upgrade powers ORCL rebound

Oracle stock price today jumps again as OpenAI-linked upgrade powers ORCL rebound

Oracle shares rose 3.4% to $161.92 Tuesday after D.A. Davidson upgraded the stock, citing upside from OpenAI-linked cloud demand and new AI features in Oracle Fusion apps. Analyst Gil Luria set a $180 target, noting Oracle’s 15% stake in a U.S. TikTok venture and potential new OpenAI funding. The rally follows a 9.6% jump Monday. Oracle’s debt load and heavy AI infrastructure spending remain in focus.
10 February 2026
·
AppLovin stock price rises again after CapitalWatch apology, with APP earnings up next

AppLovin stock price rises again after CapitalWatch apology, with APP earnings up next

AppLovin shares rose about 3% to $474.31 Tuesday morning, extending a rebound after CapitalWatch retracted parts of its allegations about shareholder Tang Hao. The stock jumped 13% Monday after the correction and apology. Jefferies called recent fears “overblown” and reaffirmed a buy rating. AppLovin reports quarterly results after the bell on Feb. 11.
10 February 2026
···
1 … 124 125 126 127 128 … 755

Stock Market Today

  • Structure Therapeutics (GPCR) Valuation Falters Amid Share Price Decline
    April 26, 2026, 10:46 PM EDT. Structure Therapeutics (GPCR) shares dropped to $45.49, marking a 49.21% decline over 90 days despite a strong 91.62% one-year total return. The biotech's price-to-book (P/B) ratio of 2.1x appears undervalued versus peers' average of 31.2x and the US pharmaceuticals sector average of 2.6x, suggesting cautious investor sentiment. This ratio compares market value to book value, often used for early-stage or loss-making companies. GPCR faces risks from ongoing clinical trials for GSBR-1290 and significant net losses of $141.2 million. Analyst forecasts predict 56.5% annual revenue growth, but uncertainties linger. Investors should balance potential gains with risks, monitoring clinical outcomes and funding capabilities amid a volatile healthcare sector.

Latest article

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

Kratos Defense Stock Slides Again as Drone Maker’s $1 Billion Growth Bet Faces Test

26 April 2026
Kratos Defense shares dropped 6.5% to $61.26, cutting its market value to $10.6 billion as investors questioned the pace of profit from new contracts. The company recently completed the first flight of its Mk1 Firejet drone and won a Space Force contract worth up to $446.8 million. AeroVironment, L3Harris, and Northrop Grumman also declined. Kratos raised $1.17 billion in a February share offering.
Robinhood’s Earnings Week Now Has a Prediction-Market Problem

Robinhood’s Earnings Week Now Has a Prediction-Market Problem

26 April 2026
Wisconsin sued Robinhood and several rivals over sports event contracts, alleging illegal sports betting through prediction markets. The lawsuit comes days before Robinhood reports first-quarter earnings on Tuesday. Robinhood shares closed at $84.71 Friday, down from $91.28 on Monday. The company said its event contracts are federally regulated and it will defend itself.
SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

SoFi Technologies Stock Faces a Big Q1 Earnings Test as Loan Growth Comes Into Focus

26 April 2026
SoFi will report first-quarter results before markets open April 29, with management projecting about $1.04 billion in adjusted net revenue and adjusted EPS of 12 cents. Shares closed at $18.44 Friday, valuing the company at $23.8 billion. The company recently launched a digital HELOC and formed a Real Estate Advisory Council. Last quarter, loan originations rose 46% to $10.5 billion and fee-based revenue climbed 53%.
Go toTop